Jefferies sees higher market share for Australia's Monash IVF, raises PT

Monash IVF

17/02/2022 23:40

** Jefferies raises PT on Australia's Monash IVF Group Ltd
 MVF.AX  stock to A$1.32 from A$1.22; retains "buy" rating 
    ** The assisted reproductive services provider on Thursday
posted HY adj net profit from ordinary activities after tax
attributable of A$13.3 mln ($9.56 mln), up 11.6%  urn:newsml:reuters.com:*:nFWN2UR1J1
    ** Brokerage expects Australian Assistive Reproductive
Services (ARS) market to grow in FY22 as community perceptions
about IVF changes; sees growth over longer term
    ** Says co saw increased market share in South Australia,
Queensland, and New South Wales, with stable market share in
Victoria
    ** Raises 2022 net profit estimate by 2.7% to A$26.2
    ** Five of 5 analysts rate the stock "buy" or higher; their
median PT is A$1.20 – Refinitiv data
    ** Stock up 5.7% this year, as of last close
 
     ($1 = 1.3914 Australian dollars)
    

 (Reporting by Jaskiran Singh in Bengaluru)
 ((Jaskiran.Singh@thomsonreuters.com;))